Product Information
PALIPERIDONE ER 9 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.2437 per EA under NDC 43975035203. Its NADAC has been published 321 times since May 6, 2020.
Strength
9 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
43975035203
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PALIPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA204452On Market Since
11/27/2019
Pharmacological Classes
Price Statistics
The NADAC for PALIPERIDONE ER 9 MG TABLET has been published 321 times since May 6, 2020, and over the history we have for it it has declined 89.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2437 per EA |
|---|---|
| All-time high | $12.5424 (Jun 10, 2020) |
| All-time low | $1.2437 (Jun 17, 2026) |
| 52-week high | $1.6995 |
| 52-week low | $1.2437 |
| Median price | $2.8365 |
| Average price | $4.7773 |
| Largest weekly change | +65.2% (Aug 21, 2024) |
| Weeks tracked | 321 |
| Tracking since | May 6, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PALIPERIDONE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PALIPERIDONE ER 9 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 9 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $1.2437 per EA (NDC 43975035203), effective Jun 24, 2026.
How has the price of PALIPERIDONE ER 9 MG TABLET changed over time?
Over the history we have for it, the NADAC for PALIPERIDONE ER 9 MG TABLET has declined 89.8%. It has been tracked across 321 weekly CMS publications since May 6, 2020.
What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 9 MG TABLET?
Since May 6, 2020, the NADAC for PALIPERIDONE ER 9 MG TABLET has ranged from a low of $1.2437 (Jun 17, 2026) to a high of $12.5424 (Jun 10, 2020), with a median of $2.8365 per EA.
Are there cheaper alternatives to PALIPERIDONE ER 9 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PALIPERIDONE ER 9 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PALIPERIDONE ER 9 MG TABLET?
PALIPERIDONE ER 9 MG TABLET (NDC 43975035203) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification